AptarGroup (ATR) stock has been on the minds of many investors recently, as the share price has moved lower over the past month. The decline has drawn attention to how the company is valued at this ...
Investor's Business Daily on MSN
Biotech Leader Travere Therapeutics Eyes Buy Point After More Than Doubling
Thursday's IBD 50 Growth Stocks To Watch pick, biotech leader Travere Therapeutics TVTX, is approaching its latest buy point ...
In contrast to all that, many investors prefer to focus on companies like AptarGroup (NYSE:ATR), which has not only revenues, but also profits. While this doesn't necessarily speak to whether it's ...
In addition to Raymond James, AptarGroup also received a Buy from Wells Fargo’s Gabrial Hajde in a report issued on October 14. However, on October 9, Bank of America Securities maintained a Hold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback